![Sergej M. Kiprijanov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sergej M. Kiprijanov
No open positions remaining
Profile
Dr. Sergej M.
Kiprijanov is a Director-Preclinical & Biologics at BerGenBio AS.
Dr. Kiprijanov was previously employed as a Principal by Novoplant GmbH, Head-Research & Development by Affimed Therapeutics AG, a Principal by German Cancer Research Center, and VP-Discovery, Research & Preclinical Development by Affitech A.
He received his undergraduate degree from Novosibirsk State University and a doctorate degree from the Moscow Institute of Physics & Technology.
Former positions of Sergej M. Kiprijanov
| Companies | Position | End |
|---|---|---|
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Chief Tech/Sci/R&D Officer | 2005-12-31 |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services Offers biomedical research services | Corporate Officer/Principal | - |
| ONCOINVENT ASA | Corporate Officer/Principal | - |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Corporate Officer/Principal | - |
Novoplant GmbH
 Novoplant GmbH Agricultural Commodities/MillingProcess Industries Develops and provides veterinary medicines | Chief Tech/Sci/R&D Officer | 2009-11-04 |
Training of Sergej M. Kiprijanov
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Develops and provides veterinary medicines | Process Industries |
Moscow Institute of Physics & Technology
 Moscow Institute of Physics & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novosibirsk State University
 Novosibirsk State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services Offers biomedical research services | Health Services |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
- Stock Market
- Insiders
- Sergej M. Kiprijanov
